Market revenue in 2023 | USD 62.8 million |
Market revenue in 2030 | USD 79.2 million |
Growth rate | 3.4% (CAGR from 2023 to 2030) |
Largest segment | Controls |
Fastest growing segment | Calibrators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Controls, Calibrators |
Key market players worldwide | Siemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.
Controls was the largest segment with a revenue share of 48.41% in 2023. Horizon Databook has segmented the Japan in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is anticipated to account for a significant share of the Asia Pacific IVD quality control market, as it has one of the most developed healthcare markets in the region. Moreover, Japan is a rapidly aging Asian country.
According to the World Economic Forum, around 25% of the country’s population is aged 65 years & above, which is expected to increase to 40% by 2060. The growing geriatric population is anticipated to boost the demand for IVD and associated products for early stage disease diagnosis with high accuracy.
Moreover, the presence of local players, such as Sysmex Corporation, has facilitated access to IVD quality control products in the country. These key players are adopting organic growth strategies to attain a competitive edge in the market. For instance, in September 2019, Sysmex Corporation.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan in vitro diagnostics quality control market , including forecasts for subscribers. This country databook contains high-level insights into Japan in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account